Omega Funds — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Immunicimmunic-therapeutics.comNASDAQ: IMUXOct 2022SEC filingmedium confidence

Biotechnology company developing orally available therapies for chronic inflammatory and autoimmune diseases.

BiotechNew York, US

Andreas Muehler(Executive Officer)inDaniel Vitt(Executive Officer, Director)inJASON TARDIO(Executive Officer)GLENN WHALEY(Executive Officer)INDERPAL SINGH(Executive Officer)Patrick Walsh(Executive Officer)

Board seatVincent Ossipow· per SEC Form D · $60M raise · filed Oct 2022

Co-investorsBayern Kapital bmp Ventures Fund+Pontifax Venture Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.